Plasminogen activators promote excitotoxicity-induced retinal damage

FASEB Journal

Volumn 19, Issue 10, 2005, Pages 1280-1289

  Mali, Raghuveer S ^a   Cheng, Mei ^a   Chintala, Shravan K ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

Excitotoxicity; Ganglion cells; Kainic acid; Retina; Tissue plasminogen activator; Urokinase plasminogen activator and non nMDA receptors

Indexed keywords

ALPHA 2 ANTIPLASMIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLASMIN; PLASMIN INHIBITOR; PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLINDNESS; CONTROLLED STUDY; ENZYME ACTIVITY; EXCITOTOXICITY; EXTRACELLULAR SPACE; GENE CONTROL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; RETINA AMACRINE CELL; RETINA GANGLION CELL; RETINA INJURY; UPREGULATION; VITREOUS BODY;

ANIMALS; APOPTOSIS; EXCITATORY AMINO ACID AGONISTS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MICE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; RETINA; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 23444453671     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-3403com     Document Type: Article

References (77)

1. Osborne, N. N., Melena, J., Chidlow, G., and Wood, J. P. (2001) A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br. J. Ophthalmol. 85, 1252-1259
2. Osborne, N. N., Casson, R. J., Wood, J. P., Chidlow, G., Graham, M., and Melena, J. (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147
3. Flammer, J., Orgul, S., Costa, V. P., Orzalesi, N., Krieglstein, G. K., Serra, L. M., Renard, J. P., and Stefansson, E. (2002) The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 21, 359-393
4. Selles-Navarro, I., Villegas-Perez, M. P., Salvador-Silva, M., Ruiz-Gomez, J. M., and Vidal-Sanz, M. (1996) Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 37, 2002-2014
5. Osborne, N. N., and Larsen, A. K. (1996) Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem. Int. 29, 263-270
6. Dreyer, E. B., Zurakowski, D., Schumer, R. A., Podos, S. M., and Lipton, S. A. (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114, 299-305
7. Lipton, S. A. (2003) Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv. Ophthalmol. 48, Suppl. 1, S38-S46
8. Ambati, J., Chalam, K. V., Chawla, D. K., D'Angio, C. T., Guillet, E. G., Rose, S. J., Vanderlinde, R. E., and Ambati, B. K. (1997) Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch. Ophthalmol. 115, 1161-1166
9. Barber, A. J. (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 283-290
10. Schwarcz, R., and Coyle, J. T. (1977) Kainic acid: neurotoxic effects after intraocular injection. Invest. Ophthalmol. Vis. Sci. 16, 141-148
11. Sucher, N. J., Lipton, S. A., and Dreyer, E. B. (1997) Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 37, 3483-3493
12. Nakanishi, S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603
13. Osborne, N. N., Ugarte, M., Chao, M., Chidlow, G., Bae, J. H., Wood, J. P., and Nash, M. S. (1999) Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43, Suppl. 1, S102-S128
14. Osborne, N. N., Larsen, A., and Barnett, N. L. (1995) Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase- containing cells. Invest. Ophthalmol. Vis. Sci. 36, 1692-1700
15. Brandstatter, J. H., Hartveit, E., Sassoe-Pognetto, M., and Wassle, H. (1994) Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur. J. Neurosci. 6, 1100-1112
16. Fletcher, E. L., and Kalloniatis, M. (1997) Localisation of amino acid neurotransmitters during postnatal development of the rat retina. J. Comp. Neurol. 380, 449-471
17. Lucas, D. R., and Newhouse, J. P. (1957) The toxic effects so sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol. 58, 193-201
18. Olney, J. W. (1969) Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J. Neuropathol. Exp. Neurol. 28, 455-474
19. Sisk, D. R., Kuwabara, T., and Kirsch, A. D. (1984) Behavioral recovery in albino rats with glutamate-damaged retinas. Invest. Ophthalmol. Vis. Sci. 25, 1124-1128
20. Sisk, D. R., and Kuwabara, T. (1985) Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate. Graefes Arch. Clin. Exp. Ophthalmol. 223, 250-258
21. Morgan, I. G., and Ingham, C. A. (1981) Kainic acid affects both plexiform layers of chicken retina. Neurosci. Lett. 21, 275-280
22. Izumi, Y., Benz, A M., Kurby, C. O., Labruyere, J., Zorumski, C. F., Price, M. T., and Olney, J. W. (1995) An ex vivo rat retinal preparation for excitotoxicity studies. J. Neurosci. Methods 60, 219-225
23. Izumi, Y., Kirby-Sharkey, C. O., Benz, A. M., Labruyere, J., Price, M. T., Wozniak, D. F., Zorumski, C. F., and Olney, J. W. (1995) Age dependent sensitivity of the rat retina to the excitotoxic action of N-methyl-D-aspartate. Neurobiol. Dis. 2, 139-144
24. Siliprandi, R., Canella, R., Carmignoto, G., Schiavo, N., Zanellato, A., Zanoni, R., and Vantini, G. (1992) N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8, 567-573
25. Manabe, S., and Lipton, S. A. (2003) Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest. Ophthalmol. Vis. Sci. 44, 385-392
26. Yoles, E., and Schwartz, M. (1998) Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch. Ophthalmol. 116, 906-910
27. Kirn, T. W., Kang, K. B., Choung, H. K., Park, K. H., and Kim, D. M. (2000) Elevated glutamate levels in the vitreous body of an in vivo model of optic nerve ischemia. Arch. Ophthalmol. 118, 533-536
28. Vorwerk, C. K., Zurakowski, D., McDermott, L. M., Mawrin, C., and Dreyer, E. B. (2004) Effects of axonal injury on ganglion cell survival and glutamate homeostasis. Brain Res. Butt. 62, 485-490
29. Brooks, D. E., Garcia, G. A., Dreyer, E. B., Zurakowski, D., and Franco-Bourland, R. E. (1997) Vitreous body glutamate concentration in dogs with glaucoma. Am. J. Vet. Res. 58, 864-867
30. Chen, Z. L., and Strickland, S. (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917-925
31. Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L., and Strickland, S. (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17, 543-552
32. Tsirka, S. E., Rogove, A. D., and Strickland, S. (1996) Neuronal cell death and tPA. Nature (London) 384, 123-124
33. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266
34. Seeds, N. W., Williams, B. L., and Bickford, P. C. (1995) Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 270, 1992-1994
35. Huang, Y. Y., Bach, M. E., Lipp, H. P., Zhuo, M., Wolfer, D. P., Hawkins, R. D., Schoonjans, L., Kandel, E. R., Godfraind, J. M., Mulligan, R., et al. (1996) Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc. Natl. Acad. Sci. USA 93, 8699-8704
36. Friedman, G. C., and Seeds, N. W. (1995) Tissue plasminogen activator mRNA expression in granule neurons coincides with their migration in the developing cerebellum. J. Comp. Neurol. 360, 658-670
37. Krystosek, A., and Seeds, N. W. (1981) Plasminogen activator secretion by granule neurons in cultures of developing cerebellum. Proc. Natl. Acad. Sci. USA 78, 7810-7814
38. Krystosek, A., and Seeds, N. W. (1981) Plasminogen activator release at the neuronal growth cone. Science 213, 1532-1534
39. Moonen, G., Grau-Wagemans, M. P., and Selak, I. (1982) Plasminogen activator-plasmin system and neuronal migration. Nature (London) 298, 753-755
40. Nakajima, K., Reddington, M., Kohsaka, S., and Kreutzberg, G. W. (1996) Induction of urokinase-type plasminogen activator in rat facial nucleus by axotomy of the facial nerve. J. Neurochem. 66, 2500-2505
41. Majka, S., McGuire, P., Colombo, S., and Das, A. (2001) The balance between proteinases and inhibitors in a murine model of proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 42, 210-215
42. Das, A., McGuire, P. G., Eriqat, C., Ober, R. R., Dejuan, E., Jr., Williams, G. A., McLamore, A., Biswas, J., and Johnson, D. W. (1999) Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest. Ophthalmol. Vis. Sci. 40, 809-813
43. Tripathi, R. C., Tripathi, B. J., and Park, J. K. (1990) Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study. Exp. Eye Res. 51, 545-552
44. Tripathi, R. C., Park, J. K., Tripathi, B. J., and Millard, C. B. (1988) Tissue plasminogen activator in human aqueous humor and its possible therapeutic significance. Am. J. Ophthalmol. 106, 719-722
45. Tripathi, B. J., Geanon, J. D., and Tripathi, R. C. (1987) Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. Ophthalmology 94, 1434-1438
46. Schacke, W., Beck, K. F., Pfeilschifter, J., Koch, F., and Hattenbach, L. O. (2002) Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Invest. Ophthalmol. Vis. Sci. 43, 2799-2805
47. Lutty, G. A., Ikeda, K., Chandler, C., and McLeod, D. S. (1991) Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid. Invest. Ophthalmol. Vis. Sci. 32, 237-245
48. Fernandez-Monreal, M., Lopez-Atalaya, J. P., Benchenane, K., Leveille, F., Cacquevel, M., Plawinski, L., MacKenzie, E. T., Bu, G., Buisson, A., and Vivien, D. (2004) Is tissue-type plasminogen activator a neuromodulator? Mol. Cell. Neurosci. 25, 594-601
49. Benchenane, K., Lopez-Atalaya, J. P., Fernandez-Monreal, M., Touzani, O., and Vivien, D. (2004) Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci. 27, 155-160
50. Johnson, M. W., Olsen, K. R., and Hernandez, E. (1992) Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage. Ophthalmology 99, 515-521
51. Lewis, H., Resnick, S. C., Flannery, J. G., and Straatsma, B. R. (1991) Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am. J. Ophthalmol. 111, 197-204
52. Lewis, H., and VanderBrug Medendorp, S. (1997) Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial. Ophthalmology 104, 1847-1851 (discussion 1852)
53. Hesse, L., Schmidt, J., and Kroll, P. (1999) Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch. Clin. Exp. Ophthalmol. 237, 273-277
54. Hesse, L., Schroeder, B., Heller, G., and Kroll, P. (2000) Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage. Retina 20, 500-505
55. Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., and Lipton, S. A. (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228-231
56. Traynelis, S. F., and Lipton, S. A. (2001) Is tissue plasminogen activator a threat to neurons? Nat. Med. 7, 17-18
57. Masos, T., and Miskin, R. (1997) mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Mol. Brain Res. 47, 157-169
58. Tsirka, S. E. (1997) Clinical implications of the involvement of tPA in neuronal cell death. J. Mol. Med. 75, 341-347
59. Tsirka, S. E., Bugge, T. H., Degen, J. L., and Strickland, S. (1997) Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc. Natl. Acad. Sci. USA 94, 9779-9781
60. Tsirka, S. E., Gualandris, A., Amaral, D. G., and Strickland, S. (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature (London) 377, 340-344
61. Irvine, W. D., Johnson, M. W., Hernandez, E., and Olsen, K. R. (1991) Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch. Ophthalmol. 109, 718-722
62. Hrach, C. J., Johnson, M. W., Hassan, A. S., Lei, B., Sieving, P. A., and Elner, V. M. (2000) Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch. Ophthalmol. 118, 659-663
63. Chen, S. N., Ho, C. L., Kuo, Y. H., and Ho, J. D. (2001) Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures. Retina 21, 460-463
64. Esser, P., Heimann, K., Bartz-Schmidt, K. U., Walter, P., Krott, R., and Weller, M. (1997) Plasminogen in proliferative vitreoretinal disorders. Br. J. Ophthalmol. 81, 590-594
65. Zhang, X., Cheng, M., and Chintala, S. K. (2004) Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest. Ophthalmol. Vis. Sci. 45, 2374-2383
66. Zhang, X., Chaudhry, A., and Chintala, S. K. (2003) Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol. Vis. 9, 238-248
67. Chintala, S. K., Zhang, X., Austin, J. S., and Fini, M. E. (2002) Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J. Biol. Chem. 277, 47461-47468
68. Vorwerk, C. K., Gorla, M. S., and Dreyer, E. B. (1999) An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv. Ophthalmol 43, Suppl. 1, S142-S150
69. Vorwerk, C. K., Lipton, S. A., Zurakowski, D., Hyman, B. T., Sabel, B. A., and Dreyer, E. B. (1996) Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37, 1618-1624
70. Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E. T., Vivien, D., and Buisson, A. (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 7, 59-64
71. Christow, S. P., Bychkov, R., Schroeder, C., Dietz, R., Haller, H., Dumler, I., and Gulba, D. C. (1999) Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores. Eur. J. Biochem. 265, 264-272
72. Gualandris, A., Jones, T. E., Strickland, S., and Tsirka, S. E. (1996) Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J. Neurosci. 16, 2220-2225
73. Rogove, A. D., Siao, C., Keyt, B., Strickland, S., and Tsirka, S. E. (1999) Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J. Cell Sci. 112, 4007-4016
74. Thanos, S. (1991) The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina. Eur. J. Neurosci. 3, 1189-1207
75. Thanos, S., Mey, J., and Wild, M. (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13, 455-466
76. Thanos, S., and Naskar, R. (2004) Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Exp. Eye Res. 79, 119-129
77. Siao, C. J., and Tsirka, S. E. (2002) Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J. Neurosci. 22, 3352-3358